Predictors of the effects of 4 years of growth hormone replacement on bone mineral density in patients with adult-onset growth hormone deficiency - A KIMS database analysis

Clinical Endocrinology

Volumn 79, Issue 2, 2013, Pages 178-184

  Tritos, Nicholas A ^a   Hamrahian, Amir H ^b   King, Donna ^c   Greenspan, Susan L ^d   Cook, David M ^e   Jönsson, Peter J ^c   Koltowska Häggstrom, Maria ^c   Biller, Beverly M K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c PFIZER INC   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ESTROGEN; GLUCAGON; GLUCOCORTICOID; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; HYPOPHYSIS HORMONE; LEVOTHYROXINE; SEX HORMONE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ADULT; ADULT DISEASE; ANDROGEN THERAPY; ARTICLE; BODY MASS; BONE DENSITOMETRY; BONE DENSITY; CLINICAL PRACTICE; CORTICOTROPIN DEFICIENCY; DIABETES INSIPIDUS; DRUG DOSE TITRATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GONADOTROPIN DEFICIENCY; GROWTH HORMONE DEFICIENCY; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; HYPOPITUITARISM; INSULIN TOLERANCE TEST; LONG TERM CARE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROVOCATION TEST; RETROSPECTIVE STUDY; TREATMENT DURATION;

ADULT; AGE OF ONSET; BONE DENSITY; DATABASES, FACTUAL; FEMALE; FEMUR NECK; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84880053846     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12132     Document Type: Article

References (34)

1. Drake, W.M., Rodriguez-Arnao, J., Weaver, J.U., et al,. (2001) The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. Clinical Endocrinology (Oxford), 54, 525-532.
2. Elbornsson, M., Gotherstrom, G., Bosaeus, I., et al,. (2012) Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. European Journal of Endocrinology, 166, 787-795.
3. Elbornsson, M., Gotherstrom, G., Franco, C., et al,. (2012) Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency. European Journal of Endocrinology, 166, 181-189.
4. Fideleff, H.L., Boquete, H.R., Stalldecker, G., et al,. (2008) Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Growth Hormone & IGF Research, 18, 318-324.
5. Gotherstrom, G., Bengtsson, B.A., Bosaeus, I., et al,. (2007) Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency. European Journal of Endocrinology, 156, 55-64.
6. Snyder, P.J., Biller, B.M., Zagar, A., et al,. (2007) Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency. Journal of Bone and Mineral Research, 22, 762-770.
7. Greenspan, S.L., &, Greenspan, F.S., (1999) The effect of thyroid hormone on skeletal integrity. Annals of Internal Medicine, 130, 750-758.
8. Fernandez-Rodriguez, E., Stewart, P.M., &, Cooper, M.S., (2009) The pituitary-adrenal axis and body composition. Pituitary, 12, 105-115.
9. Debono, M., Ross, R.J., &, Newell-Price, J., (2009) Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. European Journal of Endocrinology, 160, 719-729.
10. Venken, K., Callewaert, F., Boonen, S., et al,. (2008) Sex hormones, their receptors and bone health. Osteoporosis International, 19, 1517-1525.
11. Gutierrez, L.P., Koltowska-Haggstrom, M., Jonsson, P.J., et al,. (2008) Registries as a tool in evidence-based medicine: example of KIMS (Pfizer International Metabolic Database). Pharmacoepidemiology and Drug Safety, 17, 90-102.
12. Ho, K.K., (2007) Consensus guidelines for the diagnosis and treatment of adults with GH deficiency II: a statement of the GH Research Society in association with the European Society for Pediatric Endocrinology, Lawson Wilkins Society, European Society of Endocrinology, Japan Endocrine Society, and Endocrine Society of Australia. European Journal of Endocrinology, 157, 695-700.
13. Tritos, N.A., Greenspan, S.L., King, D., et al,. (2011) Unreplaced sex steroid deficiency, corticotropin deficiency, and lower IGF-I are associated with lower bone mineral density in adults with growth hormone deficiency: a KIMS database analysis. Journal of Clinical Endocrinology and Metabolism, 96, 1516-1523.
14. Tritos, N.A., Hamrahian, A.H., King, D., et al,. (2012) A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis. European Journal of Endocrinology, 167, 343-351.
15. Riis, P., (2003) Thirty years of bioethics: the Helsinki Declaration 1964-2003. New Review of Bioethics, 1, 15-25.
16. Filipsson, H., Monson, J.P., Koltowska-Haggstrom, M., et al,. (2006) The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. Journal of Clinical Endocrinology and Metabolism, 91, 3954-3961.
17. Underwood, L.E., Attie, K.M., &, Baptista, J., (2003) Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 88, 5273-5280.
18. Brabant, G., von zur Muhlen, A., Wuster, C., et al,. (2003) Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Hormone Research 60, 53-60.
19. Rota, F., Savanelli, M.C., Tauchmanova, L., et al,. (2008) Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender. Journal of Endocrinological Investigation, 31, 94-102.
20. Arwert, L.I., Roos, J.C., Lips, P., et al,. (2005) Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men. Clinical Endocrinology (Oxford), 63, 310-316.
21. Rahim, A., Holmes, S.J., Adams, J.E., et al,. (1998) Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy. Clinical Endocrinology (Oxford), 48, 463-469.
22. Hazem, A., Elamin, M.B., Bancos, I., et al,. (2012) Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis. European Journal of Endocrinology, 166, 13-20.
23. Bachrach, L.K., Hastie, T., Wang, M.C., et al,. (1999) Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study. Journal of Clinical Endocrinology and Metabolism, 84, 4702-4712.
24. Baroncelli, G.I., Bertelloni, S., Sodini, F., et al,. (2003) Acquisition of bone mass in normal individuals and in patients with growth hormone deficiency. Journal of Pediatric Endocrinology and Metabolism, 16 (Suppl. 2), 327-335.
25. Neer, R.M., Arnaud, C.D., Zanchetta, J.R., et al,. (2001) Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. New England Journal of Medicine, 344, 1434-1441.
26. Bex, M., Abs, R., Maiter, D., et al,. (2002) The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: a 2-year open randomized controlled multicenter trial. Journal of Bone and Mineral Research, 17, 1081-1094.
27. Bex, M., &, Bouillon, R., (2003) Growth hormone and bone health. Hormone Research, 60 (Suppl. 3), 80-86.
28. Bravenboer, N., Holzmann, P.J., ter Maaten, J.C., et al,. (2005) Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men. Journal of Bone and Mineral Research, 20, 1778-1784.
29. Joseph, F., Ahmad, A.M., Ul-Haq, M., et al,. (2008) Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis. Journal of Bone and Mineral Research, 23, 721-729.
30. Sugimoto, T., Kaji, H., Nakaoka, D., et al,. (2002) Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis. European Journal of Endocrinology, 147, 339-348.
31. Tritos, N.A., &, Biller, B.M., (2009) Growth hormone and bone. Current Opinion in Endocrinology, Diabetes, and Obesity, 16, 415-422.
32. Cook, D.M., (2004) Growth hormone and estrogen: a clinician's approach. Journal of Pediatric Endocrinology and Metabolism, 17 (Suppl. 4), 1273-1276.
33. Cook, D.M., Ludlam, W.H., &, Cook, M.B., (1999) Route of estrogen administration helps to determine growth hormone (GH) replacement dose in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 84, 3956-3960.
34. Abs, R., &, Feldt-Rasmussen, U, eds. (2004) The KIMS 2004 Aetiology of Growth Hormone Deficiency (KIMS Classification List). In: Growth Hormone Deficiency in Adults: 10 Years of KIMS. Oxford PharmaGenesis™ Ltd, Oxford, 346-348.